Niagen Bioscience
(NASDAQ) NAGE
Niagen Bioscience Financials at a Glance
Market Cap
$336.34M
Revenue (TTM)
$129.42M
Net Income (TTM)
$17.38M
EPS (TTM)
$0.20
P/E Ratio
20.54
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$4.29
Volume
26,979
Open
$4.22
Price
$4.29
Volume
26,979
Open
$4.22
Previous Close
$4.29
Daily Range
$4.17 - $4.29
52-Week Range
$4.17 - $14.69
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$4.29
Volume
26,979
Open
$4.22
Previous Close
$4.29
Daily Range
$4.17 - $4.29
52-Week Range
$4.17 - $14.69
NAGE News
NAGE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Niagen Bioscience
Industry
Personal Products
Sector
Consumer StaplesEmployees
117
CEO
Robert N. Fried, MBA
Website
www.niagenbioscience.comHeadquarters
Los Angeles, CA 90024, US
NAGE Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
11%
Net Income Margin
13%
Return on Equity
28%
Return on Capital
17%
Return on Assets
16%
Earnings Yield
4.87%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$336.34M
Shares Outstanding
80.08M
Volume
26.98K
Short Interest
0.00%
Avg. Volume
1.22M
Financials (TTM)
Gross Profit
$83.19M
Operating Income
$14.30M
EBITDA
$15.75M
Operating Cash Flow
$13.44M
Capital Expenditure
$292.00K
Free Cash Flow
$13.14M
Cash & ST Invst.
$64.79M
Total Debt
$2.82M
Niagen Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$33.84M
+16.2%
Gross Profit
$21.70M
+19.3%
Gross Margin
64.14%
N/A
Market Cap
$336.34M
N/A
Market Cap/Employee
$3.23M
N/A
Employees
104
N/A
Net Income
$4.13M
-42.4%
EBITDA
$2.97M
-60.3%
Quarterly Fundamentals
Net Cash
$61.97M
+48.1%
Accounts Receivable
$9.74M
+25.4%
Inventory
$20.42M
+122.2%
Long Term Debt
$1.81M
+9.5%
Short Term Debt
$1.00M
+0.8%
Return on Assets
16.34%
N/A
Return on Invested Capital
16.53%
N/A
Free Cash Flow
$523.00K
-93.9%
Operating Cash Flow
$624.00K
-92.7%